Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1994 Apr 25;22(8):1389–1393. doi: 10.1093/nar/22.8.1389

Antibodies generated from human immunoglobulin miniloci in transgenic mice.

S D Wagner 1, G T Williams 1, T Larson 1, M S Neuberger 1, D Kitamura 1, K Rajewsky 1, J Xian 1, M Brüggemann 1
PMCID: PMC307995  PMID: 8190629

Abstract

One approach to the production of human monoclonal antibodies focusses on the creation of transgenic mice bearing human immunoglobulin gene miniloci. Whilst such loci undergo lymphoid-specific gene rearrangement, only a small proportion of mouse B cells express the human immunoglobulin chains; the miniloci thus contribute poorly to serum immunoglobulin. Attributing this poor performance to competition between the transgenic and endogenous immunoglobulin loci, we crossed mice bearing a human immunoglobulin heavy-chain (HulgH) minilocus with animals that had been rendered B cell-deficient by disruption of their endogenous heavy-chain locus. The results were dramatic: the human minilocus rescued B cell differentiation such that effectively all B cells now expressed human mu chains. The concentration of antibody in the mouse serum recognised by anti-human mu increased to a concentration about one sixth that in human serum. The HulgH antibodies are heterogenous with diversity being generated by both combinatorial and junctional processes. Following antigen challenge, specific antibody is elicited but at low titre.

Full text

PDF
1389

Images in this article

1391Image
on p.1391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams P. G., Rossio J. L., Stevenson H. C., Foon K. A. Optimal strategies for developing human-human monoclonal antibodies. Methods Enzymol. 1986;121:107–119. doi: 10.1016/0076-6879(86)21012-5. [DOI] [PubMed] [Google Scholar]
  2. Adair J. R. Engineering antibodies for therapy. Immunol Rev. 1992 Dec;130:5–40. doi: 10.1111/j.1600-065x.1992.tb01519.x. [DOI] [PubMed] [Google Scholar]
  3. Boulianne G. L., Hozumi N., Shulman M. J. Production of functional chimaeric mouse/human antibody. Nature. 1984 Dec 13;312(5995):643–646. doi: 10.1038/312643a0. [DOI] [PubMed] [Google Scholar]
  4. Brüggemann M., Caskey H. M., Teale C., Waldmann H., Williams G. T., Surani M. A., Neuberger M. S. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6709–6713. doi: 10.1073/pnas.86.17.6709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brüggemann M., Spicer C., Buluwela L., Rosewell I., Barton S., Surani M. A., Rabbitts T. H. Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus. Eur J Immunol. 1991 May;21(5):1323–1326. doi: 10.1002/eji.1830210535. [DOI] [PubMed] [Google Scholar]
  6. Brüggemann M., Winter G., Waldmann H., Neuberger M. S. The immunogenicity of chimeric antibodies. J Exp Med. 1989 Dec 1;170(6):2153–2157. doi: 10.1084/jem.170.6.2153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Choi T. K., Hollenbach P. W., Pearson B. E., Ueda R. M., Weddell G. N., Kurahara C. G., Woodhouse C. S., Kay R. M., Loring J. F. Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome. Nat Genet. 1993 Jun;4(2):117–123. doi: 10.1038/ng0693-117. [DOI] [PubMed] [Google Scholar]
  8. Coffman R. L. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol Rev. 1982;69:5–23. doi: 10.1111/j.1600-065x.1983.tb00446.x. [DOI] [PubMed] [Google Scholar]
  9. Davies N. P., Rosewell I. R., Richardson J. C., Cook G. P., Neuberger M. S., Brownstein B. H., Norris M. L., Brüggemann M. Creation of mice expressing human antibody light chains by introduction of a yeast artificial chromosome containing the core region of the human immunoglobulin kappa locus. Biotechnology (N Y) 1993 Aug;11(8):911–914. doi: 10.1038/nbt0893-911. [DOI] [PubMed] [Google Scholar]
  10. Jones P. T., Dear P. H., Foote J., Neuberger M. S., Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. 1986 May 29-Jun 4Nature. 321(6069):522–525. doi: 10.1038/321522a0. [DOI] [PubMed] [Google Scholar]
  11. Kitamura D., Roes J., Kühn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991 Apr 4;350(6317):423–426. doi: 10.1038/350423a0. [DOI] [PubMed] [Google Scholar]
  12. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  13. Marks J. D., Hoogenboom H. R., Bonnert T. P., McCafferty J., Griffiths A. D., Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol. 1991 Dec 5;222(3):581–597. doi: 10.1016/0022-2836(91)90498-u. [DOI] [PubMed] [Google Scholar]
  14. Morrison S. L., Johnson M. J., Herzenberg L. A., Oi V. T. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6851–6855. doi: 10.1073/pnas.81.21.6851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Neuberger M. S., Williams G. T., Mitchell E. B., Jouhal S. S., Flanagan J. G., Rabbitts T. H. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature. 1985 Mar 21;314(6008):268–270. doi: 10.1038/314268a0. [DOI] [PubMed] [Google Scholar]
  16. O'Brien R. L., Brinster R. L., Storb U. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice. 1987 Mar 26-Apr 1Nature. 326(6111):405–409. doi: 10.1038/326405a0. [DOI] [PubMed] [Google Scholar]
  17. Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature. 1988 Mar 24;332(6162):323–327. doi: 10.1038/332323a0. [DOI] [PubMed] [Google Scholar]
  18. Sharpe M. J., Milstein C., Jarvis J. M., Neuberger M. S. Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J. 1991 Aug;10(8):2139–2145. doi: 10.1002/j.1460-2075.1991.tb07748.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Taylor L. D., Carmack C. E., Schramm S. R., Mashayekh R., Higgins K. M., Kuo C. C., Woodhouse C., Kay R. M., Lonberg N. A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins. Nucleic Acids Res. 1992 Dec 11;20(23):6287–6295. doi: 10.1093/nar/20.23.6287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tomlinson I. M., Walter G., Marks J. D., Llewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol. 1992 Oct 5;227(3):776–798. doi: 10.1016/0022-2836(92)90223-7. [DOI] [PubMed] [Google Scholar]
  21. Tuaillon N., Taylor L. D., Lonberg N., Tucker P. W., Capra J. D. Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3720–3724. doi: 10.1073/pnas.90.8.3720. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES